Securing the ofloxacin–ornidazole combination in the Democratic Republic of the Congo
Orapuh Journal · 15.06.2026 · 7 (3) · e1430
DOI: 10.4314/orapj.v7i3.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orapuh Journal, online erschienen am 15.06.2026. Verfasst von Shabani und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Pharmaceutical stability in tropical regions is a critical public health concern, as extreme heat and humidity can compromise drug integrity before the expiry date.
Purpose
This cross-sectional analytical study, incorporating experimental stability testing, aimed to evaluate the effects of architectural microclimates and hygrothermal conditions on the stability of the ofloxacin–ornidazole combination in the Democratic Republic of the Congo (DRC).
Methods
Observational field sampling (N = 30), combined with laboratory stability testing, was conducted in Kinshasa, Kisangani, and Bukavu. Laboratory stability was assessed using a validated spectrophotometric method.
Results
Drug content levels in Kinshasa pharmacies, characterized by uninsulated iron roofs, showed statistically significant underdosing (87.27% ± 1.45; p < .001; 95% CI [85.8, 88.7]) compared with the 98.40% ± 0.55 observed in temperate Bukavu (p < .001).
Conclusion
Building architecture and physical integrity (e.g., tablet crushing) are major determinants of drug quality in Climatic Zone IVb. The observed underdosing may compromise therapeutic efficacy and represents a recognized risk factor for accelerating antimicrobial resistance, as supported by global climatic models.
Zitieren
APA
Shabani, L., M., Nsengimana, S., Tweni, E., B., Mbinze, J., K., Marini, & R., D. (2026). Securing the ofloxacin–ornidazole combination in the Democratic Republic of the Congo. Orapuh Journal, 7(3), e1430. https://doi.org/10.4314/orapj.v7i3.30
Vancouver
Shabani, L. M, Nsengimana, S., Tweni, E. B, et al. Securing the ofloxacin–ornidazole combination in the Democratic Republic of the Congo. Orapuh Journal. 2026;7(3):e1430. doi:10.4314/orapj.v7i3.30
BibTeX
@article{Shabani2026,
author = {Shabani and L., M. and Nsengimana and S. and Tweni and E., B. and Mbinze and J., K. and Marini and R., D.},
title = {Securing the ofloxacin–ornidazole combination in the Democratic Republic of the Congo},
journal = {Orapuh Journal},
year = {2026},
volume = {7},
number = {3},
pages = {e1430},
doi = {10.4314/orapj.v7i3.30}
}
EUVIMED